skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cytokine profiling for prediction of symptomatic radiation-induced lung injury

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [3];  [3];  [3];  [3];  [4];  [1];  [1];  [3];  [3]
  1. Department of Pathology, Duke University Medical Center, Durham, NC (United States)
  2. Cancer Center Biostatistics, Duke University Medical Center, Durham, NC (United States)
  3. Department of Radiation Oncology, Duke University Medical Center, Durham, NC (United States)
  4. Department of Medicine, Duke University Medical Center, Durham, NC (United States)

Purpose: To analyze plasma cytokine profiles before the initiation of radiation therapy to define a cytokine phenotype that correlates with risk of developing symptomatic radiation-induced lung injury (SRILI). Methods and Materials: Symptomatic radiation-induced lung injury was evaluated in 55 patients (22 with SRILI and 33 without SRILI), according to modified National Cancer Institute common toxicity criteria. These plasma samples were analyzed by the multiplex suspension bead array system (Bio-Rad Laboratories; Hercules, CA), which included the following cytokines: interleukin (IL)-1{beta}, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, IL-17, granulocyte/macrophage colony-stimulating factor, interferon-{gamma}, monocyte chemotactic protein 1, macrophage inflammatory protein 1{beta}, tumor necrosis factor {alpha}, and granulocyte colony-stimulating factor. Results: Significant differences in the median values of IL-8 were observed between patients with and without SRILI. Patients who did not develop SRILI had approximately fourfold elevated levels of IL-8 as compared with patients who did subsequently develop SRILI. Significant correlations were not found for any other cytokine in this study, including transforming growth factor {beta}1. Conclusions: Patients with lower levels of plasma IL-8 before radiation therapy might be at increased risk for developing SRILI. Further studies are necessary to determine whether IL-8 levels are predictive of SRILI in a prospective trial and whether this marker might be used to determine patient eligibility for dose escalation.

OSTI ID:
20788238
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 63, Issue 5; Other Information: DOI: 10.1016/j.ijrobp.2005.05.032; PII: S0360-3016(05)00942-9; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Cytokine and Growth Factor Responses After Radiotherapy for Localized Ependymoma
Journal Article · Fri May 01 00:00:00 EDT 2009 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20788238

Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro
Journal Article · Wed Sep 01 00:00:00 EDT 1993 · American Journal of Respiratory Cell and Molecular Biology; (United States) · OSTI ID:20788238

Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines
Journal Article · Mon May 01 00:00:00 EDT 1995 · Journal of Nuclear Medicine · OSTI ID:20788238